Literature DB >> 4027120

Effect of charcoal-drug ratio on antidotal efficacy of oral activated charcoal in man.

K T Olkkola.   

Abstract

The effect of charcoal-drug ratio on the antidotal efficacy of oral activated charcoal was studied in six healthy volunteers in a randomized cross-over study and compared with the adsorption capacity of activated charcoal in vitro. Aminosalicylic acid (PAS) 1 g and 5 g were ingested on an empty stomach in 30 ml of water. Immediately afterwards the subjects ingested 50 g of activated charcoal in 300 ml of water or 300 ml of water only. PAS 10 g 20 g were only given with 50 g of activated charcoal administered immediately afterwards. The plasma concentrations and the cumulative excretion of PAS into urine were measured for 48 h. Increasing the dose of PAS from 1 g to 20 g reduced the antidotal efficacy of activated charcoal: at a charcoal-drug ratio of 50:1 under 5% of the dose was absorbed but at a ratio of 2.5:1 about 37%. These data correlated well to the saturation of adsorption capacity of charcoal in vitro. To minimize the possibility of saturation of the adsorption capacity of charcoal in acute intoxications where the amount and type of drug taken is usually unknown, large doses (50-100 g) of activated charcoal should be used.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027120      PMCID: PMC1463870          DOI: 10.1111/j.1365-2125.1985.tb02712.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  [Formation and excretion of RHO-aminosalicylic acid metabolites].

Authors:  H LAUENER; J HODLER; G FAVEZ; E DETTWILER; L HADORN
Journal:  Klin Wochenschr       Date:  1957-04-15

Review 2.  Use of activated charcoal in acute poisoning.

Authors:  J W Hayden; E G Comstock
Journal:  Clin Toxicol       Date:  1975       Impact factor: 4.467

3.  Optimal antidotal dose of activated charcoal.

Authors:  L Chin; A L Picchioni; W M Bourn; H E Laird
Journal:  Toxicol Appl Pharmacol       Date:  1973-09       Impact factor: 4.219

4.  Effect of activated charcoal on aspirin absorption in man. Part I.

Authors:  G Levy; T Tsuchiya
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

Review 5.  Clinical pharmacokinetics of oral activated charcoal in acute intoxications.

Authors:  P J Neuvonen
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

6.  Effect of activated charcoal on acetaminophen absorption.

Authors:  G Levy; J B Houston
Journal:  Pediatrics       Date:  1976-09       Impact factor: 7.124

7.  Effect of dose of charcoal on the absorption of disopyramide, indomethacin and trimethoprim by man.

Authors:  P J Neuvonen; K T Olkkola
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  7 in total
  4 in total

Review 1.  Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.

Authors:  P J Neuvonen; K T Olkkola
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec

2.  Gastrointestinal decontamination in the acutely poisoned patient.

Authors:  Timothy E Albertson; Kelly P Owen; Mark E Sutter; Andrew L Chan
Journal:  Int J Emerg Med       Date:  2011-10-12

Review 3.  Drugs and pharmaceuticals: management of intoxication and antidotes.

Authors:  Silas W Smith
Journal:  EXS       Date:  2010

4.  Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis.

Authors:  Ben Gold; Julia Roberts; Yan Ling; Landys Lopez Quezada; Jou Glasheen; Elaine Ballinger; Selin Somersan-Karakaya; Thulasi Warrier; J David Warren; Carl Nathan
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.